US Patent Issued to Thomas Malcolm on July 15 for "Tailored hypoimmune nanovesicular delivery systems for cancer tumors" (New Jersey Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,704, issued on July 15, was assigned to Thomas Malcolm (Andover, N.J.).

"Tailored hypoimmune nanovesicular delivery systems for cancer tumors" was invented by Thomas Malcolm (Andover, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Hypoimmunogenic induced pluripotent stem cell (iPSC)-derived biomimetic nanovesicles (hypo-bioNVs) including tailored chimeric antigen receptor (CARs) which can recognize target biomarkers through an antibody fragment scFV region or by a viral epitope recognition receptor (VERR). A method of making hypo-bioNVs. A method of treating an individual with cancer, by administering the hypo-bioNVs to an individual, targeting...